CinRx Pharma LLC 13D/13G Filings for CinCor Pharma, Inc. (CINC)

CinRx Pharma LLC 13D and 13G filings for CinCor Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-01-11
4:05 pm
Purchase
2022-01-0613GCinCor Pharma, Inc.
CINC
CinRx Pharma LLC3,630,102
7.800%
3,630,102increase
(New Position)
Filing